Genprex, Inc. — Director's Dealing 2018

May 25, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Genprex, Inc. (GNPX)
CIK: 0001595248
Period of Report: 2018-05-23

Reporting Person: Pham Julien L (President & COO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-05-23	Stock option (right to buy)	$9.80	A	659346	Acquired	2028-05-23	Common Stock (659346)	Direct

Footnotes

F1: 1/2 of the shares vest as follows: 1/3 of such shares vest one year after 5/23/2018; the remaining 2/3 of such shares vest in equal quarterly installments over the following 2 years. The other 1/2 of the shares vest on achievement of performance goals.